Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $100.69 million. The enterprise value is -$67.10 million.

Market Cap	100.69M
Enterprise Value	-67.10M

Important Dates

The next estimated earnings date is Thursday, March 20, 2025, before market open.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Cabaletta Bio has 48.88 million shares outstanding. The number of shares has increased by 29.67% in one year.

Current Share Class	48.88M
Shares Outstanding	48.88M
Shares Change (YoY)	+29.67%
Shares Change (QoQ)	+0.05%
Owned by Insiders (%)	3.10%
Owned by Institutions (%)	65.53%
Float	41.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.58
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.11, with a Debt / Equity ratio of 0.09.

Current Ratio	8.11
Quick Ratio	8.00
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.16% and return on invested capital (ROIC) is -40.36%.

Return on Equity (ROE)	-62.16%
Return on Assets (ROA)	-37.89%
Return on Invested Capital (ROIC)	-40.36%
Return on Capital Employed (ROCE)	-63.08%
Revenue Per Employee	n/a
Profits Per Employee	-$1.01M
Employee Count	103
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.93% in the last 52 weeks. The beta is 2.47, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y)	2.47
52-Week Price Change	-90.93%
50-Day Moving Average	2.47
200-Day Moving Average	5.40
Relative Strength Index (RSI)	38.29
Average Volume (20 Days)	1,356,753

Short Selling Information

The latest short interest is 6.25 million, so 12.79% of the outstanding shares have been sold short.

Short Interest	6.25M
Short Previous Month	6.45M
Short % of Shares Out	12.79%
Short % of Float	15.04%
Short Ratio (days to cover)	4.62

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-114.50M
Pretax Income	-89.98M
Net Income	-104.16M
EBITDA	-112.92M
EBIT	-114.50M
Earnings Per Share (EPS)	-$2.16

Full Income Statement

Balance Sheet

The company has $183.01 million in cash and $15.22 million in debt, giving a net cash position of $167.79 million or $3.43 per share.

Cash & Cash Equivalents	183.01M
Total Debt	15.22M
Net Cash	167.79M
Net Cash Per Share	$3.43
Equity (Book Value)	174.24M
Book Value Per Share	3.57
Working Capital	162.63M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$81.55 million and capital expenditures -$2.02 million, giving a free cash flow of -$83.57 million.

Operating Cash Flow	-81.55M
Capital Expenditures	-2.02M
Free Cash Flow	-83.57M
FCF Per Share	-$1.71

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.67%
Shareholder Yield	-29.67%
Earnings Yield	-103.45%
FCF Yield	-83.00%

Analyst Forecast

The average price target for Cabaletta Bio is $26.13, which is 1,168.45% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$26.13
Price Target Difference	1,168.45%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-4.75%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1